Search results
Novavax's updated COVID-19 vaccine gets FDA approval
United Press International via Yahoo News· 8 months agoFederal regulators on Tuesday gave the go-ahead to an updated Novavax COVID-19 vaccine, giving Americans a more traditional alternative to two recently...
FDA Authorizes Updated Novavax COVID-19 Vaccine
Verywell Health via Yahoo News· 8 months agoNovavax's updated COVID-19 vaccine is now authorized for U.S. teens and adults. The protein-based vaccine is the only immunization option that does not...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 1 month agoFor Immediate Release Chicago, IL – May 17, 2024 – Zacks.com announces the list of stocks featured...
Novavax (NVAX) Down as EU Adds Side Effects to COVID Jab Label
Zacks via Yahoo Finance· 2 years agoThe administration of Novavax's (NVAX) COVID-19 vaccine leads to some cases of severe allergic...
The Zacks Analyst Blog Highlights Geron, Chemomab Therapeutics, Phathom Pharmaceuticals, Vera...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 6, 2023 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis...
Zacks via Yahoo Finance· 10 months agoFor Immediate Release Chicago, IL – August 25, 2023 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna and Novavax
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – September 13, 2023 – Zacks.com announces the list of stocks...
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoNovavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript February 28, 2024 Novavax, Inc. misses...
Biotech Stock Roundup: NERV, RLMD Down on Updates, MRNA, NVAX's News & More
Zacks via Yahoo Finance· 2 years agoIt was a busy week for the volatile biotech sector, with important regulatory and pipeline updates...
Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) knows that it needs new products. The good news is that Moderna has three...